CS1:PA:PA-Amundi IBEX 35 UCITS ETF Acc (EUR)

ETF | Others |

Last Closing

USD 332.55

Change

+1.35 (+0.41)%

Market Cap

USD 0.11B

Volume

856.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.54 (+1.22%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.20 (+0.04%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.35 (+0.10%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

+0.07 (+0.21%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.24 (+0.50%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.75 (-0.18%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.77 (+0.24%)

USD 7.49B
HHH:PA HSBC S&P 500 UCITS ETF

+0.01 (+0.03%)

USD 7.22B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.01 (-0.10%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.05 (+0.07%)

USD 5.38B

ETFs Containing CS1:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.38% 98% N/A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.38% 98% N/A 87% B+
Trailing 12 Months  
Capital Gain 25.68% 95% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.68% 95% A 89% A-
Trailing 5 Years  
Capital Gain 124.21% 96% N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 124.21% 96% N/A 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.86% 85% B 81% B-
Dividend Return 15.86% 84% B 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.87% 50% F 73% C
Risk Adjusted Return 123.24% 96% N/A 96% N/A
Market Capitalization 0.11B 30% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.